Literature DB >> 15990221

Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment.

Andreas Josefsson1, Pernilla Wikström, Torvald Granfors, Lars Egevad, Lars Karlberg, Pär Stattin, Anders Bergh.   

Abstract

OBJECTIVES: To investigate the prognostic value of potential markers in localized, Gleason score 6 and 7 prostate cancer (PC).
METHODS: From a consecutive series of men with PC diagnosed at transurethral resection (1975-1990), specimens from 132 patients without metastases, with Gleason score (GS) 6 (n=80) or 7 (n=52) tumors followed with watchful waiting were examined. The fraction of resected prostate tissue containing cancer, the micro-vessel density (v.d.) when stained for endoglin or von Willebrand factor (vWf), and the percentage of Ki-67 labeled tumor cells were measured using immunohistochemistry.
RESULTS: High levels of vWf v.d., endoglin v.d., and percent cancer of the TURP specimen were significantly associated with short cancer-specific survival in Kaplan-Meier analysis of all patients with GS 6 and 7 tumors. Interestingly, a combined estimate of percent cancer and vWF v.d. could be used to identify a large subset (50%) of GS 6 tumors with only a 2.5% risk of PC death within 15 years. None of the tested markers gave independent prognostic information for the GS 7 tumors.
CONCLUSIONS: Estimates of tumor size and vascular density may identify a large proportion of non-aggressive GS 6, but not GS 7, tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990221     DOI: 10.1016/j.eururo.2005.05.016

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  15 in total

1.  Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.

Authors:  Borna K Barth; Pieter J L De Visschere; Alexander Cornelius; Carlos Nicolau; Hebert Alberto Vargas; Daniel Eberli; Olivio F Donati
Journal:  Radiology       Date:  2017-03-27       Impact factor: 11.105

2.  Endoglin regulates cancer-stromal cell interactions in prostate tumors.

Authors:  Diana Romero; Christine O'Neill; Aleksandra Terzic; Liangru Contois; Kira Young; Barbara A Conley; Raymond C Bergan; Peter C Brooks; Calvin P H Vary
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

3.  Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.

Authors:  Andreas Josefsson; Hani Adamo; Peter Hammarsten; Torvald Granfors; Pär Stattin; Lars Egevad; Anna Engström Laurent; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

4.  Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.

Authors:  Christina Hägglöf; Peter Hammarsten; Andreas Josefsson; Pär Stattin; Janna Paulsson; Anders Bergh; Arne Ostman
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

5.  Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.

Authors:  Edward A Sykes; Qin Dai; Christopher D Sarsons; Juan Chen; Jonathan V Rocheleau; David M Hwang; Gang Zheng; David T Cramb; Kristina D Rinker; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

6.  H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples.

Authors:  Katarina Stenman; Pär Stattin; Hans Stenlund; Katrine Riklund; Gerhard Gröbner; Anders Bergh
Journal:  Biomark Insights       Date:  2011-03-14

7.  A comparison of bladder neck preservation and bladder neck reconstruction for urinary incontinence after radical retro pubic prostatectomy.

Authors:  Mohammad Hossein Izadpanahi; Ramin Honarmand; Mohammad Hataf Khorrami; Mohammad Reza Najarzadegan; Mehrdad Mohammadi Sichani; Farshid Alizadeh
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

8.  High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.

Authors:  Peter Hammarsten; Tove Dahl Scherdin; Christina Hägglöf; Pernilla Andersson; Pernilla Wikström; Pär Stattin; Lars Egevad; Torvald Granfors; Anders Bergh
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

9.  The prognostic significance of vasohibin-1 expression in patients with prostate cancer.

Authors:  T Kosaka; Y Miyazaki; A Miyajima; S Mikami; Y Hayashi; N Tanaka; H Nagata; E Kikuchi; K Nakagawa; Y Okada; Y Sato; M Oya
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

10.  Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.

Authors:  Jenny Häggström; Mariateresa Cipriano; Linus Plym Forshell; Emma Persson; Peter Hammarsten; Nephi Stella; Christopher J Fowler
Journal:  Prostate       Date:  2014-06-09       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.